The extraordinary conceitedness of being an anti-vaxxer : r/skeptic

Eugenics & Covid Deaths
Covid-19 speeds up ‘zombie cell’ production
Naturally occurring “zombie or senescent cells” are being produced at an accelerated rate due to Covid-19, according to a recent study.
Underlying cause of 'brain fog' linked with long COVID discovered
Scientists have announced a major discovery that has profound importance for our understanding of brain fog and cognitive decline seen in some patients with Long COVID. The findings showed that there was disruption to the integrity of the blood vessels in the brains of patients suffering from Long COVID and brain fog. This blood vessel 'leakiness' was able to objectively distinguish those patients with brain fog and cognitive decline compared to patients suffering from Long-COVID but not with brain fog.
Lighting up Long Covid - by Eric Topol - Ground Truths
An important new mechanistic study and a blitz of other reports that help our understanding
Immune damage in Long Covid
Links between the complement and coagulation systems could lead to Long Covid therapies
For millions of Canadians with long COVID, getting treatment is still a struggle
Long COVID sufferers from across Canada are left struggling for words, breath and answers after some specialized clinics have shut down.
When Someone Died Suddenly, What Could Be the Cause? Hint: It’s Not the Vaccine
A new, rigorous study sheds light on 5 top causes.
SARS-CoV-2 Infection is Associated with an Increase in New Diagnoses of Schizophrenia Spectrum and Psychotic Disorder: A Study Using the US National COVID Cohort Collaborative (N3C)
Amid the ongoing global repercussions of SARS-CoV-2, it’s crucial to comprehend its potential long-term psychiatric effects. Several recent studies have suggested a link between COVID-19 and subsequent mental health disorders. Our investigation joinsthis exploration, concentrating on Schizophrenia Spectrum and Psychotic Disorders (SSPD). Different from other studies, we took acute respiratory distress syndrome (ARDS) and COVID-19 lab negative cohorts as control groups to accurately gauge the impact of COVID-19 on SSPD. Data from 19,344,698 patients, sourced from the N3C Data Enclave platform, were methodically filtered to create propensity matched cohorts: ARDS (n = 222,337), COVID-positive (n = 219,264), and COVID-negative (n = 213,183). We systematically analyzed the hazard rate of new-onset SSPD across three distinct time intervals: 0-21 days, 22-90 days, and beyond 90 days post-infection. COVID-19 positive patients consistently exhibited a heightened hazard ratio (HR) across all intervals [0-21 days (HR: 4.6; CI: 3.7-5.7), 22-90 days (HR: 2.9; CI: 2.3 -3.8), beyond 90 days (HR: 1.7; CI: 1.5-1.)]. These are notably higher than both ARDS and COVID-19 lab-negative patients. Validations using various tests, including the Cochran Mantel Haenszel Test, Wald Test, and Log-rank Test confirmed these associations. Intriguingly, our data indicated that younger individuals face a heightened risk of SSPD after contracting COVID-19, a trend not observed in the ARDS and COVID-negative groups. These results, aligned with the known neurotropism of SARS-CoV-2 and earlier studies, accentuate the need for vigilant psychiatric assessment and support in the era of Long-COVID, especially among younger populations.
### Competing Interest Statement
The authors have declared no competing interest.
### Clinical Protocols
https://ncats.nih.gov/n3c/resources.
### Funding Statement
Yes
### Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
WVU CTSI, WVU IRB and N3C Publication Committee
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The data underlying the results presented in the study are available from https://covid.cd2h.org/ which requires institutional access.
Korean Autopsy Study Reveals Nationwide Rate of Sudden Cardiac Death From mRNA Vaccines at…
A final piece to the puzzle left unresolved in my prior work.